Results 41 to 50 of about 1,351 (83)
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis
Canadian Respiratory Journal, 1995 OBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP).
RA McIvor +4 more
doaj +1 more source
BMC Infectious Diseases, 2009 Background In patients with chronic respiratory disease, Pneumocystis jirovecii (P. jirovecii) colonization is observed, and may influence disease progression and systemic inflammation.
Shimizu Yasuo +6 more
doaj +1 more source
Клиническая онкогематология, 2014 Pneumocystis pneumonia is a rare complication of a high-dose chemotherapy and autologous bone marrow/peripheral hematopoietic stem cells transplantation in patients with hematological malignances.
V. O. Sarzhevskii +5 more
doaj +1 more source
Clinical and translational research in Pneumocystis and Pneumocystis pneumonia*
Parasite, 2011 Pneumocystis pneumonia (PcP) remains a significant cause of morbidity and mortality in immunocompromised persons, especially those with human immunodeficiency virus (HIV) infection.
Huang L.
doaj +1 more source
Canadian Journal of Infectious Diseases and Medical Microbiology, 2015 BACKGROUND: Pneumocystis jirovecii (PJ), a pathogenic fungus, causes severe interstitial Pneumocystis pneumonia (PCP) among immunocompromised patients. A laboratory-developed real-time polyermase chain reaction (PCR) assay was validated for PJ detection ...
Deirdre L Church +7 more
doaj +1 more source
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2019 Atousa HAKAMIFARD, Somayeh HAJIAHMADI
doaj +1 more source